Anthropic Confirms Bay Area Wet Biology Lab — SkimNews
Get the Tech newsletter
Daily tech — startups, AI labs, chips, the launches that shape the next decade. Free.
- Anthropic confirmed to TechCrunch it operates a wet biology lab in the Bay Area where it uses its AI models to conduct physical experiments, with head of life sciences Eric Kauderer-Abrams telling Reuters the lab operates like most biotech labs, doing internal research alongside external partner work
- Anthropic said the lab's main focus is fundamental biology, not drug discovery — a deliberate framing to avoid competing with its pharma customers, including a newly announced joint drug-discovery deal with Novo Nordisk
- Anthropic acquired stealth AI biotech Coefficient Bio in April, a precursor to launching the wet lab, and this week also rolled out a Life Sciences Verification Program giving vetted bio researchers access to its most powerful models
- Anthropic researcher Jacob Coxon resigned with a warning that 'the people building AI earnestly believe that it could kill us all by the end of the decade,' and CEO Dario Amodei published a post last weekend calling on the industry to slow down and self-regulate
- Amodei has repeatedly called bioterrorism one of AI's biggest risks, a contrast investor Chamath Palihapitiya highlighted on X: 'The group behind such hits as: We're All Going To Die and Regulate Me Now are building a wet lab in SF.'
Why it matters: Anthropic is walking a tightrope between two contradictory postures: expanding into physical biology research while publicly warning that AI poses extinction-level risks including bioterrorism. The choice to frame the lab as 'fundamental biology' rather than drug discovery is a direct concession to pharma customers like Novo Nordisk, who would revolt if a model provider competed with them — and Anthropic has already faced backlash for products seen as competing with customers.
Ask SkimNews
